A century-old heart medication derived from the foxglove plant may offer a new way to combat the spread of cancer, according to recent research. Scientists have discovered that the drug, traditionally used to treat heart conditions, can help break down clusters of cancer cells that contribute to metastasis. These clumps, known as circulating tumor cell clusters, are a major factor in cancer spreading throughout the body, making them a crucial target for treatment.
By repurposing this well-established drug, researchers hope to develop a new approach to limiting cancer progression with minimal side effects. Since the medication has already been extensively studied for heart conditions, its safety profile is well understood, potentially accelerating its approval for cancer treatment. This discovery highlights the importance of exploring existing medications for new therapeutic uses, offering hope for more effective cancer interventions in the future. Click for More Details
